共 50 条
- [31] A feasibility study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphomaJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Kahl, B. S.Peterson, C.Blank, J.McFarland, T.Huie, M.Eickhoff, J.Werndli, J.Callander, N.Myers, T.
- [32] Successful Treatment of Paraneoplastic Mesangioproliferative Glomerulonephritis in Mantle Cell Lymphoma Using Acalabrutinib and RituximabINDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,Wadhera, SarthakSwain, Rudra NarayanSaini, ShashikantSekar, ArvindSharma, PraveenSethi, JasmineSachdeva, Man UpdeshMalhotra, Pankaj
- [33] First line treatment of mantle cell lymphoma with high dose cytarabine and rituximabBRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 51 - 51Forbes, A.Rule, S.Farrell, K.McKay, P.Bolam, S.Kruger, A.
- [34] Rituximab-Bendamustine Cytarabine (R-BAC) As Frontline Therapy in Mantle Cell Lymphoma: A Single-Center ExperienceBLOOD, 2015, 126 (23)Branca, AntonioGianesello, IlariaBrugnaro, LucaBerno, TamaraImbergamo, SilviaLessi, FedericaSammartin, KetyVianello, FabrizioAdami, FaustoBinotto, GianniGurrieri, CarmelaTrentin, LivioVisco, CarloZambello, RenatoPiazza, FrancescoSemenzato, Gianpietro
- [35] A Window Study of Acalabrutinib Plus Rituximab Followed By R-Dhaox (rituximab, dexamethasone, cytarabine, oxaliplatin) and Autologous Stem Cell Transplant (ASCT) in Fit Mantle Cell Lymphoma (MCL): The Australasian Leukaemia & Lymphoma Group (ALLG) NHL33 Wamm TrialBLOOD, 2021, 138Hawkes, ElizaAgrawal, ShivamLee, Sze-TingWight, JoelHapgood, GregArmytage, TasmanDoo, Nicole WongCochrane, TaraCheah, Chan-YoonBilmon, IanKu, MatthewOpat, StephenDevitt, BiancaFong, Chun YewFancourt, TinekeWalia, MannuNkhoma, GloriaBarraclough, Allison
- [36] Initial Results of a Phase II Study of Sequential Chemotherapy and Lenalidomide Followed By Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell LymphomaBLOOD, 2018, 132Kumar, AnitaZelenetz, Andrew D.Batlevi, Connie LeeCaron, PhilipDogan, AhmetDrullinsky, PamelaGerecitano, JohnHamilton, AudreyHamlin, Paul A.Laraque, LeanaMatasar, Matthew J.McCall, Susan JenniferMoskowitz, Alison J.Moskowitz, Craig H.Owens, ColettePichardo, JanineSchoder, HeikoSigler, AllisonStraus, David J.Younes, Anas
- [37] Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)BLOOD, 2023, 142Visco, CarloTabanelli, ValentinaSacchi, Maria VittoriaEvangelista, AndreaFerrarini, IsaccoTisi, Maria ChiaraMerli, AnnaFiori, StefanoZilioli, Vittorio RuggeroRe, AlessandroCastellino, ClaudiaPiazza, FrancescoCorradini, PaoloHohaus, StefanMusuraca, GerardoRossi, Francesca GaiaPuccini, BenedettaCavallo, FedericaBallerini, FilippoSciarra, RobertaDi Rocco, AliceArcari, AnnalisaBoccomini, CarolaMerli, FrancescoGini, GuidoTani, MonicaBruna, RiccardoPavone, VincenzoFerreri, Andres Jose MariaSantoro, ArmandoPatti, CaterinaLoseto, GiacomoLadetto, MarcoMerli, MicheleSpina, MicheleZinzani, Pier LuigiStefani, Piero MariaUsai, SaraPileri, StefanoBalzarotti, Monica
- [38] Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphomaLeukemia, 2015, 29 : 1695 - 1701G HessU KellerC W ScholzM Witzens-HarigJ AttaC BuskeS KirscheyC RuckesC MedlerC van OordtW KlapperM TheobaldM Dreyling
- [39] Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma over 60 Years of Age (PrE0405): A Phase II StudyBLOOD, 2019, 134Portell, Craig A.Bennani, N. NoraJegede, OpeyemiNaik, SeemaParsons, Benjamin M.Patel, Priyank P.Reynolds, Christopher M.Kahl, Brad S.
- [40] Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphomaLEUKEMIA, 2015, 29 (08) : 1695 - 1701Hess, G.Keller, U.Scholz, C. W.Witzens-Harig, M.Atta, J.Buske, C.Kirschey, S.Ruckes, C.Medler, C.van Oordt, C.Klapper, W.Theobald, M.Dreyling, M.